Contemporary Pediatrics week in review: Tool to aid in autism diagnosis, increased RSV activity, and more

News
Article

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

Contemporary Pediatrics week in review: Tool to aid in autism diagnosis, increased RSV activity, and more | Image Credit: Contemporary Pediatrics

Contemporary Pediatrics week in review: Tool to aid in autism diagnosis, increased RSV activity, and more | Image Credit: Contemporary Pediatrics

Thank you for visiting the Contemporary Pediatrics® website. Take a look at some of our top stories from last week (Monday, September 4 to Friday, September 8, 2023) and click each link to read and watch anything you may have missed.

1.) FDA-cleared tool could assist in diagnosing autism

The EarliPoint Evaluation has demonstrated positive phase 3 trial results, aiding in autism diagnosis and assessment in children aged 16 to 30 months. Warren Jones, PhD, chief scientific officer and cofounder of EarliTec Diagnostics, Inc., discusses the eye-tracking tool, how it is currently being used, and what could be in store for the future.

Click here to watch the full interview.

2.) CDC issues health advisory alert after increases in RSV activity

Due to increased RSV activity observed in Southeastern regions of the United States, the Centers for Disease Control and Prevention (CDC) has issued an official Health Alert Network Health Advisory. The CDC recommends that clinicians prepare to implement recently FDA-approved prevention methods.

Click here for the full article.

3.) GARDASIL 9 shows positive long-term results against HPV-related cancers

The effects of GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) in patients aged 9 to 15 years has indicated efficacy, according to a recent long-term follow-up study.

Click here for the full article.

4.) Pediatric T1D management adherence system evaluated in study

Numerous tools, technology platforms, and interventions have been developed to help teens with the difficult emotional and physical weight of managing the disease.

Click here for the full article.

5.) Discussing VP-102 to treat molluscum contagiosum in patients 2 years and up

In this Contemporary Pediatrics interview, Bernard A. Cohen, MD, discusses VP-102, approved by the FDA on July 22, 2023, to treat molluscum contagiosum in pediatric patients 2 years and up.

Click here to watch the full interview.

Related Videos
Juanita Mora, MD
Lauren Flagg
Traci Gonzales, MSN, APRN, CPNP-PC
William Gallentine, DO
Meghan Harrison, DO & Brittany Perry, DO
Rupa Wong, MD | Image Credit: Rupa Wong, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.